• Users Online: 655
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2012  |  Volume : 6  |  Issue : 3  |  Page : 77-82

New onset diabetes after transplantation (NODAT): Analysis of pre-transplant risk factors in renal allograft recipients


1 Professor, Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India
2 Senior Resident, Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India
3 Professor, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India

Correspondence Address:
Surendra Singh Rathore
Senior Resident, Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1016/j.ijt.2012.07.003

Get Permissions

Background: Occurrence of new onset diabetes after transplant (NODAT) has major impact on patient and graft survival, and cardiovascular mortality. Methods: In this retrospective study, among all renal transplant recipients who followed-up at our center during the period of January 1998 to April 2012, the development of NODAT was assessed by reviewing case records. Characteristics of patients with NODAT were compared with the patients who did not develop post-transplant diabetes. Results: Total 68 non-diabetic renal transplant recipients were included in analysis. Emergence of NODAT was observed in 13 (19.12%) recipients, with mean duration of onset at 52.73 ± 49.57 months post-transplant. Development of NODAT was significantly associated with; age of ≥45 years at transplant time (P 0.029, odds ratio 4.38), pre-transplant weight (P 0.031), presence of ADPKD (P 0.020, odds ratio 16.20), positive family history of diabetes (P 0.009, odds ratio 5.96), pre-transplant hypercholesterolemia (P 0.029, odds ratio 4.38), and pre-transplant hypertriglyceridemia (P 0.023, odds ratio 5.03). Risk of development of diabetes was not related to type of calcineurin inhibitor used. Conclusion: NODAT is common in our renal transplant patients. Risk of development of post-transplant diabetes was more closely related to traditional risk factors and was not influenced by immunosuppressive therapy.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed89    
    Printed11    
    Emailed0    
    PDF Downloaded24    
    Comments [Add]    
    Cited by others 5    

Recommend this journal